Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma. | Cancer Res | 2023 | 38098449 | PubTator, text mining | PubMed |
| Fascin actin-bundling protein 1 regulates non-small cell lung cancer progression by influencing the transcription and splicing of tumorigenesis-related genes. | PeerJ | 2023 | 38077434 | PubTator, text mining | PubMed |
| Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors. | Front Immunol | 2023 | 38077327 | PubTator, text mining | PubMed |
| The Multifaceted Roles of Lamins in Lung Cancer and DNA Damage Response. | Cancers (Basel) | 2023 | 38067205 | PubTator, text mining | PubMed |
| PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma. | Front Oncol | 2023 | 38023190 | PubTator, text mining | PubMed |
| Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients. | Front Oncol | 2023 | 38023151 | PubTator, text mining | PubMed |
| Canonical Wnt and TGF-β/BMP signaling enhance melanocyte regeneration but suppress invasiveness, migration, and proliferation of melanoma cells. | Front Cell Dev Biol | 2023 | 38020918 | PubTator, text mining | PubMed |
| A Strategy Utilizing Protein-Protein Interaction Hubs for the Treatment of Cancer Diseases. | Int J Mol Sci | 2023 | 38003288 | PubTator, text mining | PubMed |
| Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence. | Biomolecules | 2023 | 38002335 | PubTator, text mining | PubMed |
| DEK oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies. | J Cell Sci | 2023 | 37997922 | PubTator, text mining | PubMed |
| Embracing Heterogeneity: Challenging the Paradigm of Replisomes as Deterministic Machines. | Chem Rev | 2023 | 37971892 | PubTator, text mining | PubMed |
| Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer. | Sci Rep | 2023 | 37950047 | PubTator, text mining | PubMed |
| Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer. | Adv Sci (Weinh) | 2023 | 37949681 | PubTator, text mining | PubMed |
| EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma. | Acta Neuropathol Commun | 2023 | 37936247 | PubTator, text mining | PubMed |
| Associations of Liver Fluke Infection and Cholangiocarcinoma: A Scoping Review. | Cureus | 2023 | 37927641 | PubTator, text mining | PubMed |
| Acral melanoma: new insights into the immune and genomic landscape. | Neoplasia | 2023 | 37913653 | PubTator, text mining | PubMed |
| MmuPV1 E6 induces cell proliferation and other hallmarks of cancer. | mBio | 2023 | 37905801 | PubTator, text mining | PubMed |
| Synchronous Urinary Bladder Urothelial Carcinoma and Transitional Cell Carcinoma of the Ovary: A Case Report. | Case Rep Oncol | 2023 | 37900783 | PubTator, text mining | PubMed |
| Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead. | Int J Mol Sci | 2023 | 37894928 | PubTator, text mining | PubMed |
| Cell-Permeable Stimuli-Responsive Ubiquitin Probe for Time-Resolved Monitoring of Substrate Ubiquitination in Live Cells. | JACS Au | 2023 | 37885572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=7